These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15181741)

  • 1. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
    Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
    Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
    Bień E; Balcerska A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and prognostic significance of serum soluble interleukin 2 receptor in children with malignancies].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2006; 59(1-2):10-5. PubMed ID: 16646285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal function in boys with newly diagnosed cancer before the start of treatment.
    Wigny KM; van Dorp W; van der Kooi AL; de Rijke YB; de Vries AC; Smit M; Pluijm SM; van den Akker EL; Pieters R; Laven JS; van den Heuvel-Eibrink MM
    Hum Reprod; 2016 Nov; 31(11):2613-2618. PubMed ID: 27680030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum selenium levels in untreated children with acute lymphoblastic leukemia. I.
    Mikac-Dević M; Ferenec D; Tiefenbach A
    J Trace Elem Electrolytes Health Dis; 1990 Mar; 4(1):7-10. PubMed ID: 2135960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].
    Aulbert E; Steffens O
    Med Klin (Munich); 1990 Jan; 85(1):13-7. PubMed ID: 2179698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experience of a single Australian paediatric oncology unit. 1000 patients 1964-1987.
    McCowage GB; Vowels MR; Brown R; O'Gorman-Hughes D; White L; Marshall G
    Med J Aust; 1993 Oct; 159(7):453-5, 458. PubMed ID: 8412916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide-specific antigen (TPS) in pediatric malignancies.
    Rebhandl W; Paya K; Felberbauer FX; Fuchs R; Henkel J; Bieglmayer C; Horcher E
    Anticancer Res; 1997; 17(4B):2865-8. PubMed ID: 9329549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of ABO blood groups in acute leukaemias and lymphomas.
    Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
    Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
    Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
    Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of the radioimmunological determination of tumor markers in the diagnosis of malignant lymphomas].
    Purizhanskiĭ II; Pavlichuk SN; Toritsina LK
    Med Radiol (Mosk); 1989 Nov; 34(11):48-51. PubMed ID: 2685505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.